Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion type Assertion NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_head.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion description "[Interestingly, numbers of tumor-infiltrating CD8+IFNgamma+ cells and CD11c+CD86+ cells were 5-fold and 2.5-fold higher in I-131-treated tumors than in PBS tumors, respectively (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_provenance.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion evidence source_evidence_literature NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_provenance.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion SIO_000772 20053774 NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_provenance.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion wasDerivedFrom befree-2016 NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_provenance.
- NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_assertion wasGeneratedBy ECO_0000203 NP785319.RArdLbTGc_8FEc_14q7Q-hHPAXmUSnDS7oX8aOLHL2BHg130_provenance.